What is BioAge Labs, Inc. Common Stock's Market Cap?

BioAge Labs, Inc. Common Stock's Market Cap is $431.2M, based on as-reported figures from SEC (XBRL) filings.

What is BioAge Labs, Inc. Common Stock's Enterprise Value?

BioAge Labs, Inc. Common Stock's Enterprise Value is $112.5M, based on as-reported figures from SEC (XBRL) filings.

What is BioAge Labs, Inc. Common Stock's Price / Sales?

BioAge Labs, Inc. Common Stock's Price / Sales is 41.6×, based on as-reported figures from SEC (XBRL) filings.

What is BioAge Labs, Inc. Common Stock's EV / Revenue?

BioAge Labs, Inc. Common Stock's EV / Revenue is 10.9×, based on as-reported figures from SEC (XBRL) filings.

What is BioAge Labs, Inc. Common Stock's EV / EBITDA?

BioAge Labs, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is BioAge Labs, Inc. Common Stock's Revenue (TTM)?

BioAge Labs, Inc. Common Stock's Revenue (TTM) is $10.4M, based on as-reported figures from SEC (XBRL) filings.

What is BioAge Labs, Inc. Common Stock's Net Income (TTM)?

BioAge Labs, Inc. Common Stock's Net Income (TTM) is -$94.5M, based on as-reported figures from SEC (XBRL) filings.

What is BioAge Labs, Inc. Common Stock's EBITDA?

BioAge Labs, Inc. Common Stock's EBITDA is -$106.1M, based on as-reported figures from SEC (XBRL) filings.

What is BioAge Labs, Inc. Common Stock's Diluted EPS (TTM)?

BioAge Labs, Inc. Common Stock's Diluted EPS (TTM) is -2.06, based on as-reported figures from SEC (XBRL) filings.

What is BioAge Labs, Inc. Common Stock's EBITDA Margin?

BioAge Labs, Inc. Common Stock's EBITDA Margin is -1024.3%, based on as-reported figures from SEC (XBRL) filings.

BioAge Labs, Inc. Common Stock (BIOA) Financial Statements

BioAge Labs, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001T6RBH0

XNAS · usd

9.40▼ 0.20 (-2.03%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close9.59

Day's Range9.32 – 9.65

52-Week Range4.68 – 25.96

Volume386.6K

Avg Volume1.1M

Share Statistics

Shares Outstanding

Employees62

ExchangeXNAS

Listed2024-09-26

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about BioAge Labs, Inc. Common Stock (BIOA)

What is BioAge Labs, Inc. Common Stock's Market Cap?: BioAge Labs, Inc. Common Stock's Market Cap is $431.2M, based on as-reported figures from SEC (XBRL) filings.
What is BioAge Labs, Inc. Common Stock's Enterprise Value?: BioAge Labs, Inc. Common Stock's Enterprise Value is $112.5M, based on as-reported figures from SEC (XBRL) filings.
What is BioAge Labs, Inc. Common Stock's Price / Sales?: BioAge Labs, Inc. Common Stock's Price / Sales is 41.6×, based on as-reported figures from SEC (XBRL) filings.
What is BioAge Labs, Inc. Common Stock's EV / Revenue?: BioAge Labs, Inc. Common Stock's EV / Revenue is 10.9×, based on as-reported figures from SEC (XBRL) filings.
What is BioAge Labs, Inc. Common Stock's EV / EBITDA?: BioAge Labs, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is BioAge Labs, Inc. Common Stock's Revenue (TTM)?: BioAge Labs, Inc. Common Stock's Revenue (TTM) is $10.4M, based on as-reported figures from SEC (XBRL) filings.
What is BioAge Labs, Inc. Common Stock's Net Income (TTM)?: BioAge Labs, Inc. Common Stock's Net Income (TTM) is -$94.5M, based on as-reported figures from SEC (XBRL) filings.
What is BioAge Labs, Inc. Common Stock's EBITDA?: BioAge Labs, Inc. Common Stock's EBITDA is -$106.1M, based on as-reported figures from SEC (XBRL) filings.
What is BioAge Labs, Inc. Common Stock's Diluted EPS (TTM)?: BioAge Labs, Inc. Common Stock's Diluted EPS (TTM) is -2.06, based on as-reported figures from SEC (XBRL) filings.
What is BioAge Labs, Inc. Common Stock's EBITDA Margin?: BioAge Labs, Inc. Common Stock's EBITDA Margin is -1024.3%, based on as-reported figures from SEC (XBRL) filings.